FDA Brief

Warning letters Drugs

FDA warning letter to

PurePurge Inc.

MediumIssued Jun 2, 2021Posted Jun 8, 2021Center for Drug Evaluation and Research

FDA warned PurePurge Inc. that its MEDPURE hand sanitizers are unapproved and illegally labeled drugs.

What happened

FDA reviewed PurePurge's website on February 11, 2021 and found it directed consumers to a second site to buy MEDPURE hand sanitizers. FDA said the products are unapproved new drugs and misbranded (illegally labeled) because their claims go beyond allowed topical antiseptic uses, their ingredients do not conform to FDA's over-the-counter antiseptic rules, and the firm was not registered or drug-listed with FDA.

What FDA found

  1. The hand sanitizers are unapproved new drugs because no FDA-approved application is in effect and they are not generally recognized as safe and effective for their labeled uses.

    section 505(a) of the FD&C Act, 21 U.S.C. 355(a)
  2. The products are misbranded because they do not meet the requirements for nonprescription drugs marketed without an approved application.

    section 502(ee) of the FD&C Act, 21 U.S.C. 352(ee)
  3. Labeling claims that the products eliminate 99.99% of viruses in 15 seconds and kill viruses, fungi, mold, and spores go beyond the allowed uses for consumer antiseptic hand rubs.

    1994 TFM, 59 FR 31402, as amended by 81 FR 42912
  4. PurePurge is an active ingredient under FDA's definition based on website claims and label prominence, but hydrogen peroxide and PurePurge are not permitted active ingredients for consumer antiseptic hand rubs.

    21 CFR 201.66(b)(2); 1994 TFM, 59 FR 31402
  5. PurePurge did not register its facility with FDA as a drug manufacturer.

    section 510(i)(1) of the FD&C Act, 21 U.S.C. 360(i)(1); 21 CFR 207.17
  6. PurePurge did not list MEDPURE HAND SANITIZERS with FDA.

    section 510(j)(1) of the FD&C Act, 21 U.S.C. 360(j)(1); 21 CFR 207.41

What FDA wants

Within 15 working days after receipt, FDA asks PurePurge to notify the office in writing of steps taken to address the violations, explain how recurrence will be prevented, and include related documentation. If corrective action cannot be completed in that time, FDA asks the firm to state the reason and the time needed.

Who should pay attention

  • retailers and online marketplaces selling hand sanitizers
  • OTC hand sanitizer brands using novel ingredients or antiviral claims
  • distributors and importers of consumer antiseptic products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk